LEX Diagnostics
Lucie Matejikova is an experienced legal and administrative professional with a strong background in office management and law. Currently serving as Office Manager at LEX Diagnostics since November 2022, Lucie previously held the position of Senior Office Administrator at Accelonix UK & Ireland from May 2017 to November 2022. Lucie's legal expertise was honed at Advokátní kancelář Vych & Partners s.r.o., where Lucie worked from April 2010 to March 2017 as an Attorney at Law and from December 2005 to April 2010 as a Trainee Lawyer. Lucie holds a Master’s Degree in International Business/Trade/Commerce from Prague University of Economics and Business, a Master of Laws (LL.M.) from Universität Passau, and a Master’s Degree in Law from the University of West Bohemia in Pilsen.
This person is not in any teams
LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, atechnology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.